<DOC>
	<DOCNO>NCT01431274</DOCNO>
	<brief_summary>The overall objective study assess efficacy safety 52 week daily treatment orally inhaled tiotropium + olodaterol FDC ( deliver RESPIMAT Inhaler ) compare individual component ( tiotropium , olodaterol ) ( deliver RESPIMAT Inhaler ) patient Chronic Obstructive Pulmonary Disease ( COPD ) .</brief_summary>
	<brief_title>Tiotropium+Olodaterol Fixed Dose Combination ( FDC ) Versus Tiotropium Olodaterol Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . Diagnosis chronic obstructive pulmonary disease . 2 . Relatively stable airway obstruction post FEV1 &lt; 80 % predict normal post FEV1/FVC &lt; 70 % . 3 . Male female patient , 40 year age old . 4 . Smoking history 10 pack year . Exclusion criterion : 1 . Significant disease COPD 2 . Clinically relevant abnormal lab value . 3 . History asthma . 4 . Diagnosis thyrotoxicosis 5 . Diagnosis paroxysmal tachycardia 6 . History myocardial infarction within 1 year screen visit 7 . Unstable lifethreatening cardiac arrhythmia . 8 . Hospitalization heart failure within past year . 9 . Known active tuberculosis . 10 . Malignancy patient undergone resection , radiation therapy chemotherapy within last five year 11 . History lifethreatening pulmonary obstruction . 12 . History cystic fibrosis . 13 . Clinically evident bronchiectasis . 14 . History significant alcohol drug abuse . 15 . Thoracotomy pulmonary resection 16 . Oral ßadrenergics . 17 . Oral corticosteroid medication unstable dose 18 . Regular use daytime oxygen therapy one hour per day 19 . Pulmonary rehabilitation program six week prior screen visit 20 . Investigational drug within one month six half life ( whichever great ) prior screen visit 21 . Known hypersensitivity ßadrenergic drug , anticholinergic , BAC , EDTA 22 . Pregnant nursing woman . 23 . Women childbearing potential use highly effective method birth control 24 . Patients unable comply pulmonary medication restriction</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>